Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Michael Fitzpatrick

Premium

Personalis has hired Michael Fitzpatrick to serve as its vice president of worldwide sales.

In this position, Fitzpatrick will oversee the day-to-day management of Personalis' worldwide sales, including field sales and support.

Prior to joining the company, he spent 20 years at Applied Biosciences where he held various positions of increasing authority including vice president of North American sales and field operations, vice president of sales of the molecular biology division, and vice president of global key accounts.

He's also been OpGen's vice president of global sales and commercial development, and vice president of global sales and support for Codon Devices.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.